1396124-22-3

Upstream product

• 1396124-21-2 (R)-2-(benzyloxy)-2-((4S,5R)-5-((R)-1,2-dihydroxyethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-morpholinoethanone 
• 1188522-27-1 1-morpholino-(2-O-benzyl-3,4:5,6-di-O-isopropylidene)-D-gluconamide 

Downstream Products

• 1396124-46-1 C₃₇H₅₈O₅ 
• 1396124-47-2 C₃₅H₅₄O₅ 
• 1396124-48-3 C₃₀H₄₄O₅ 
• 1414047-02-1 C₃₉H₅₆N₂O₅S 
• 1414046-88-0 C₃₄H₄₆N₂O₅S 
• 1396124-41-6 (R)-2-(benzyloxy)-2-((4S,5R)-5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-morpholinoethanone 
• 1396124-42-7 (R)-2-(benzyloxy)-2-((4S,5R)-5-((benzyloxy)methyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-morpholinoethanone 
• 1396124-23-4 C₂₃H₃₃NO₅ 
• 1396124-24-5 C₂₇H₄₁NO₅ 
• 1396124-25-6 C₃₂H₅₁NO₅ 
• 1396124-26-7 C₃₄H₅₅NO₅ 

Relevant academic research and scientific papers

Convenient synthesis of D- and L-xylo-1,2,3,4-alkane tetrols from a D-gluco-configured common building block

D-gluco-Configured building block derived from d-(+)-gluconolactone has served as a common chiral template for the synthesis of enantiopure d- and l-xylo-configured 1,2,3,4-alkane tetrols. This has enabled synthesis of medicinally important guggultetrols and their enantiomers from a common starting point. Wittig and Grignard reactions are the key steps used for the incorporation of lipophilic chain.